ArticlePloS one2017

Correction: Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial.

PLOS ONE StaffPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.